Department of Medical Services adjusts treatment guidelines for COVID Obstructive pulmonary-heart-diabetes patients Easier access to antiretroviral drugs Enhanced Immunotherapy (LAAB) is a treatment option for this group. It is expected to be announced today, Nov. 30, 2022.
Ministry of Public Health by the Medical Department The 26th Edition of the COVID-19 Treatment Guidelines has been reviewed by the Public Health Emergency Operations Center (EOC) in case of COVID-19 and is expected to be published today, November 30, 2022. The latest revised version as follows
1. Patients with mild symptoms no pneumonia No risk factors for severe disease From the original, very detailed Modify to outpatient care. Follow DMHT for at least 5 days. Provide symptomatic care at physician’s discretion. If antiretroviral therapy is required, molnupiravir may be given. or favipiravir in children under 18 years of age.
2.Patients with mild symptoms but risk factors for severe disease or no risk factors but with mild to moderate pneumonia that does not require oxygen has adjusted the criteria for risk factors for severe disease for easier access to antiviral drugs in 3 groups:
- COPD includes other chronic lung diseases of stage 2 or higher.
- Cardiovascular disease Class 2 and above
- uncontrolled diabetes Adjusted to no stage of disease and normal diabetes. The doctor can prescribe medication at his discretion.
for the administration of antiviral drugs in this group has boosted immunity (double) entered as well, which may LAAB alone or in combination with other antiretroviral drugs according to symptoms or at the physician’s discretion
In addition, the dosage recommendations were also adjusted. by PaxLovid should start within 5 Days since symptom onset 5 day 10 The dose of remdesivir should be started in 5 Days since symptom onset 3 day 3 Dosage LAAB should start in 7 Days since symptoms gave 1 doses and molnupiravir should be started on 5 Days since symptom onset Number 5 day 10 Dosage
for the COVID situation case of deceased mostly over 70% The group is not vaccinated or less vaccinated than the needle. 3 and the last needle is too long 3 months, and some have symptoms that are not noticed or not examined think it’s influenza, so if you have a high fever, cough a lot, start panting should hurry to the hospital especially group 608 And the group that has not received the vaccine or has not received all of them, the symptoms will change quickly, so they are asked to come and see a doctor for timely diagnosis and treatment.
As for the current COVID bed situation Have returned the bed to take care of patients with other diseases, leaving the bed to take care of only COVID 7,564 bed used approx. 1,168 bed or use 19.4% only level bed 2-3 who care for the moderate to severe group, use approx. 35% Even during the new year, there will be more infected people. But it is expected that patients with severe symptoms will not increase much. Estimate that the use of the bed until this new year may not arrive. 50%
Read more
